Skip to content
  • Reports
  • Podcast
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Genfit

Genfit

ADVERTISEMENT
Best in Biotech

A Year to Remember: The Biggest European Biotech News in 2020

The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…

By Jonathan Smith
28/12/2020 - 12 minutes
News and Trends

Genfit’s Phase III Drug Fails to Treat NASH, But New Players On Horizon

Patients with the chronic liver disease NASH must now wait even longer for an approved…

By Helen Albert
13/05/2020 - 4 minutes
Interview

The First Approved NASH Therapy?

Genfit is poised to become the first company to get a treatment for NASH to…

By Helen Albert
30/07/2019 - 6 minutes
News and Trends

Genfit’s NASH Drug to Be Developed in China in Deal Worth up to €200M

The US-Chinese company Terns Pharmaceuticals will develop and commercialize Genfit’s phase III drug elafibranor for…

By Jonathan Smith
25/06/2019 - 3 minutes
News and Trends

Genfit Gets Ready to Launch Drug for Untreated Liver Disease Raising €120M

After some big failures from its top competitors earlier this year, French company Genfit has…

By Clara Rodríguez Fernández
27/03/2019 - 3 minutes
News and Trends

NASH Leader goes Pediatric with Clinical Trial Launch in US

The FDA has cleared Genfit to kick off clinical trials to see if its NASH…

By Alex Dale
23/01/2018 - 2 minutes
Best in Biotech

Bored Between the Holidays? Watch these Biotech Videos!

Christmas might have passed, but we have more videos for you to watch on a…

By Evelyn Warner
28/12/2017 - 4 minutes
News and Trends

Genfit Gets €180M Cash Injection to Bring its Pipeline to Market

Elafibranor, Genfit's lead candidate, will continue its march towards the market with the added boost of…

By Alex Dale
17/10/2017 - 3 minutes
Best in Biotech

These Three Fields Are Proving Biotech is The Innovation Powerhouse in Healthcare

Biotech is the best source of innovation in R&D, making its companies the darlings of…

By Evelyn Warner
26/09/2017 - 8 minutes
Interview

The Advantage for the First Mover in NASH is Limited, says Genfit

After we reviewed NASH earlier this year, Genfit's CSO, Dean Hum, came to speak at…

By Evelyn Warner
11/07/2017 - 4 minutes
News and Trends

Genfit Delays Phase III Enrollment in the Race for the First NASH Therapy

Genfit has announced that closing of enrollment will be delayed up to 6 months. Will…

By Clara Rodríguez Fernández
24/04/2017 - 2 minutes
News and Trends

Two Big Pharma Players Team up to Take Over the NASH Space

Allergan has entered a clinical collaboration with Novartis to run a Phase IIb study combining…

By Melanie De Almeida
18/04/2017 - 3 minutes
  • 1
  • 2
  • Next Page »
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Startups Gene therapy Synthetic biology
    Labiotech.eu
    Log In Newsletter

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast